Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of lenalidomide in human plasma and its application on bioequivalence studies
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Narenderan, S. T.
Text and Data Mining valid from 2019-11-28
21 August 2019
31 October 2019
28 November 2019
The authors declare that they have no competing interests.